Compound | menaquinone | ||||
---|---|---|---|---|---|
CAS No. | 11032-49-8 | Catalog No. | ACF0003T | Brand | |
Purity | 98% | Packing | 1kg | Grade | |
Lead Time | Origin | Loading Port |
Boiling Point | 448.6ºC at 760 mmHg |
---|---|
Storage Condition | -20ºC |
Appearance & Physical State | White crystalline powder |
Flash Point | 167.2ºC |
Refractive Index | 1.548 |
Density | 1.045 g/cm3 |
Vapor Pressure | 3.06E-08mmHg at 25°C |
The number of unsaturated isoprenoid chains on the side chain of the Vitamin K2 are varied, they are usually referred to as MK-n in brief, in which n represents the number of isoprenoid chain. The active forms of vitamin K2 are MK-7, MK-4 and MK-9. The biological activity of Vitamin K2 is significantly higher than vitamin K1. In the normal metabolism of human body, when the gastrointestinal function is in the normal state, the normal intestinal flora will the participate in the transformation from vitamin K1 or K3, K4 to vitamin K2 living body, and then they can be absorbed by the body.
properties
Appearance: yellow crystal powder.
Melting point: 33-37
Solubility: Easily soluble in n-hexane,soluble in ethanol,slightly soluble in methanol,almost insoluble in water
MK-4Reference JP14/JP15 technical indexs
CAS: [11032-49-8] or [863-61-6]
Mol. Formula: C31H40O2
Mol. Weight: 444.65
Shelf life: 2 years
Dangerous grade: Non-hazardous
Grade: Equivalent to JP 14/CP2005
Art.No. | Specification | MOQ |
DCF0004A | 0.13%Oil | 5-100kg |
DCF0004B | 0.13% powder (sustained released preparation) | 10kg |
DCF0004C | 1.3% Oil | 1-5kg |
DCF0004D | 1.3% powder (sustained released preparation) | 1kg |
DCF0004E | 98% powder | 1kg |
DCF0004F | 98% Oil | 1kg |
Function
Treat and prevent osteoporosis, bone protein can be generated by Vitamin K2 and then co-generate bone with calcium. Vitamin K2 can increase bone density and prevent fractures.
Vitamin K2 can prevent cirrhosis from developing to liver cancer.
It can treat vitamin K2 deficiency hemorrhagic disease, promote the formation of prothrombin, accelerate blood clottingand maintain normal clotting time.
It has the function of diuretic and improving the liver's detoxification.
High dietary menaquinone intake is associated with reduced coronary calcification
A high menaquinone intake reduces the incidence of coronary heart disease
Dietary intake of menaquinones is associated with reduced risk of coronary heart disease: the Rotterdam Study
vitamin K consumption is associated with cardio-metabolic disorders
Latest science study results showed that severe aortic calcification and the relative risk of CHD mortality was reduced with vitamin K2.
Application
It can be used as anti-osteoporosis drugs or nutraceuticals.
Vitamin K2 can be used as raw materials of health care product or nutrition fortifier;
It can be added to general public food as a special food additive;
CAS No : 53839-71-7
4-[(4S,5R)-1-carboxy-4-hydroxynonadeca-6,8,10,13-tetraen-5-yl]sulfanylbenzoic acid
CAS No : 154978-38-8
CAS No : 187947-37-1
CAS No : 11032-49-8
CAS No : 1859-87-6
CAS No : 77642-19-4
N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]icosa-5,8,11,14,17-pentaenamide
CAS No : 199875-71-3
CAS No : 863-61-6